Simpson Manufacturing Co., Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Simpson Manufacturing Co., Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	861	977	1,079	1,137	1,268	1,573	2,116	2,214	2,232	2,333
Cost of revenue	451	534	599	644	692	818	1,175	1,172	1,208	1,263
Gross profit	410	443	480	492	576	755	941	1,042	1,024	1,070
Research and development	10.8	10.6	10.8	10.9	10.1	12.3	15.7	24.8	20.7	11.5
Selling and marketing	98.3	115	110	113	113	135	169	204	214	223
General and administrative	125	143	159	157	161	193	228	272	293	322
Operating expenses	269	305	312	317	324	388	466	562	589	627
Operating income	141	138	173	181	252	368	459	475	430	458
Interest expense	1.15	1.18	1.06	2.03	2.28	0.85	8.03	4.49	2.27	-9.01
Other non-operating income		-0.87	-0.63	-1.73	-2.01	-1.39	-7.59	3.39	5.28	8.34
Pre-tax income	139	144	172	178	250	359	448	477	434	462
Income tax	49.2	51.8	45.5	44.4	62.6	92.1	114	123	112	117
Net income	89.7	92.6	127	134	187	266	334	354	322	345
EBITDA	169	172	212	220	291	410	520	550	515	548
EPS, basic	1.87	1.95	2.74	3.00	4.28	6.15	7.78	8.31	7.64	8.27
EPS, diluted	1.86	1.94	2.72	2.98	4.27	6.12	7.76	8.26	7.60	8.24
Shares, basic (weighted)	48.1	47.5	46.2	44.7	43.7	43.3		42.6	42.2	41.7
Shares, diluted (weighted)	48.3	47.8	46.5	44.9	43.8	43.5		42.8	42.4	41.9
Dividend per share	0.70	0.81	0.87	0.91	0.92	0.98	1.03	1.07	1.11	1.15

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	227	169	160	230	275	301	301	430	239	384
Receivables	112	136	146	139	165	231	269	284	284	303
Inventory	232	253	276	252	284	444	557	552	593	594
Other current assets	14	26.5	17.2	19.4	29.6	22.9	52.6	47.1	59.4	71.5
Total current assets	585	584	600	641	753	999	1,179	1,312	1,176	1,353
Property, plant and equipment	233	273	255	249	255	260	362	419	532	628
Lease right-of-use assets			0	35.4	45.8	45.4	57.7	68.8	93.9	115
Goodwill	124	137	130	132	136	134	496	503	512	559
Intangible assets	22.9	29.3	24.4	25.1	26.8	26.3	363	365	375	388
Other non-current assets	12.1	11.5	10.4	10.6	15.8	19.7	46.9	37	46.8	32
Total assets	980	1,038	1,022	1,095	1,233	1,484	2,504	2,705	2,736	3,074
Accounts payable	27.7	31.5	34.4	33.4	48.3	57.2	97.8	108	101	91.5
Accrued liabilities	60.5	88.5	117	126	146	187	228	231	243	275
Short-term debt		1.1	1.1			0	22.5	22.5	22.5	15
Total current liabilities	109	136	152	159	194	245	349	361	366	382
Long-term debt	0	2.6	1.6
Lease liabilities			0	27.9	37.2	37.1	46.9	55.3	76.2	96.8
Total liabilities	114	153	166	203	252	300	1,091	1,025	923	1,038
Total debt	0	3.7	2.7			0	433	411	388	300
Paid-in capital	256	260	277	280	284	294	299	313	307	325
Retained earnings	642	677	628	646	720	907	1,118	1,427	1,647	1,843
Treasury stock	0	-40	-25	-9.38	-13.5	0	0	-50.4	-101	-121
Other comprehensive income	-33	-12.5	-24.7	-24.8	-10.4	-17.6	-4.06	-9.99	-46.8	-14.6
Shareholders' equity	866	885	856	892	981	1,184	1,413	1,680	1,805	2,030
Total equity	866	885	856	892	981	1,184	1,413	1,680	1,805	2,030
Total liabilities and equity	980	1,038	1,022	1,095	1,233	1,484	2,504	2,705	2,736	3,074
Shares outstanding	47.4	46.7	45	44.2	43.3	43.3	43.3	42.3	41.9	41.3

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	89.7	92.6	127	134	187	266	334	354	322	345
Depreciation and amortization	27.9	33.7	39.4	38.4	38.8	42.5	60.9	74.7	85.4	90
Stock-based compensation	13.9	13.9	11.2	10.4	13.5	17.7	15	23.9	19	23
Deferred income tax	-0.87	6.3	4.95	2.56	3.18	-0.92	-13.2	-7.54	-4.24	11.7
Change in receivables	-7.55	-17.8	-12.6	6.1	-22.1	-68	19.8	-13.1	-3.65	-10.1
Change in inventory	-36.6	-6.58	-26.4	23.7	-27.2	-164	-28.4	15.7	-50.4	19.9
Cash from operations	99	119	160	206	208	151	400	427	338	459
Capital expenditures	-42	-58	-29.3	-32.7	-32.6	-43.7	-62.4	-88.8	-180	-161
Acquisitions	-5.36	-27.9	-2.01	-2.65	-2.8	-0.22	-811	-23.4	-79.2	-2.06
Cash from investing	-48.5	-75.8	-10.2	-28	-39.9	-58.8	-870	-103	-259	-136
Stock issued	7.98	6.61	0.7	0	0			0	0	3.53
Share buybacks	-53.5	-70	-111	-60.8	-76.2	-24.1	-78.6	-50	-100	-120
Dividends paid	-32.7	-37	-39.9	-40.2	-40.4	-41.6	-43.9	-45.2	-46.5	-47.6
Cash from financing	-83.1	-107	-155	-108	-127	-71.6	466	-199	-261	-186
Exchange rate effect			-2.77	0.54	3.49	5.64	4.48	4.34	-7.89	8.42
Net change in cash		-58	-8.33	70	44.4	26.5	-0.41	129	-190	145
Free cash flow	57	61	131	173	175	108	337	338	158	298
Interest paid	0.28	0.12	0.16	0.14	1.6	1.6	17	16.4	13.4	11.5
Income taxes paid	49.4	50.8	40.1	37.7	63	83.7	113	123	118	113

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $176.55 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	45.8%	Gross profit / revenue.
Operating margin	20.6%	Operating income / revenue.
EBITDA margin	24.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	20.9%	Pre-tax income / revenue.
Net margin	15.6%	Net income / revenue.
FCF margin	19.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	23.7%	Cash from operations / revenue.
Effective tax rate	25.1%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	17.9%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	12.1%	Net income / average total assets.
Return on invested capital (ROIC)	19.1%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	0.9%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	4.4%	Capital expenditures / revenue.
D&A / revenue	4.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	4.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	3.3%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	13.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	4.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	4.4%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	13.2%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	6.5%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-0.1%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	12.7%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	6.3%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	1.8%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	13.5%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	7.1%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	1.1%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	13.0%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	8.4%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	2.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	14.1%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	35.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	4.7%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	17.2%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	88.6%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-4.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	11.2%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	3.6%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	3.7%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	4.6%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	12.4%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	12.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	15.7%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	12.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	7.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	20.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.9%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	3.29x	Current assets / current liabilities.
Quick ratio	1.99x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.01x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.14x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	9.3%	Total debt / total assets.
Liabilities / assets	32.3%	Total liabilities / total assets.
Net debt	-$158.0M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.26x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$1.02B	Current assets - current liabilities.
Goodwill and intangibles / assets	29.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	$1.21B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.77x	Revenue / average total assets.
Fixed asset turnover	3.94x	Revenue / average property, plant and equipment.
Inventory turnover	2.56x	Cost of revenue / average inventory.
Days inventory	143 days	365 x average inventory / cost of revenue.
Receivables turnover	5.53x	Revenue / average receivables.
Days sales outstanding	66 days	365 x average receivables / revenue.
Days payables	35 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	174 days	Days inventory + days sales outstanding - days payables.
FCF conversion	123.6%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	18.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$9.23	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$58.97	Revenue / diluted weighted shares.
FCF per share	$11.40	Free cash flow / diluted weighted shares.
Operating cash flow per share	$13.98	Cash from operations / diluted weighted shares.
Book value per share	$51.56	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$29.34	Tangible book value / shares outstanding.
Cash per share	$10.97	(Cash + short-term investments) / shares outstanding.
Payout ratio	12.7%	Dividends paid / net income, when net income is positive.
Dividends / FCF	10.3%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	33.9%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$7.24B	Share price x shares outstanding.
Enterprise value	$7.08B	Market cap + total debt - cash - short-term investments.
P/E	19.1x	Market cap / net income. Only when net income is positive.
P/S	2.99x	Market cap / revenue.
P/B	3.42x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	6.00x	Market cap / tangible book value, when positive.
P/FCF	15.5x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	12.6x	Market cap / cash from operations, when positive.
EV/Sales	2.92x	Enterprise value / revenue.
EV/EBIT	14.2x	Enterprise value / operating income, when both are positive.
EV/EBITDA	11.8x	Enterprise value / EBITDA, when both are positive.
EV/FCF	15.1x	Enterprise value / free cash flow, when both are positive.
FCF yield	6.5%	Free cash flow / market cap.
Earnings yield	5.2%	Net income / market cap (the inverse of P/E).
Dividend yield	0.7%	Dividends paid over the period / market cap.
Shareholder yield	2.9%	(Dividends paid + share buybacks) / market cap.
PEG	9.45x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was Simpson Manufacturing Co., Inc.'s revenue in fiscal 2025?

Simpson Manufacturing Co., Inc. reported revenue of $2.33B for fiscal 2025, 4.5% higher than the year before.

Was Simpson Manufacturing Co., Inc. profitable in fiscal 2025?

Yes. Net income was $345.1M, a net margin of 14.8%.

How much free cash flow did Simpson Manufacturing Co., Inc. generate in fiscal 2025?

Cash from operations of $458.7M minus capital expenditures of $161.0M left free cash flow of $297.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Simpson Manufacturing Co., Inc.